scispace - formally typeset
Y

Yongkui Jing

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  110
Citations -  4755

Yongkui Jing is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Apoptosis & Acute promyelocytic leukemia. The author has an hindex of 35, co-authored 100 publications receiving 4405 citations. Previous affiliations of Yongkui Jing include Mount Sinai Hospital & Peking Union Medical College.

Papers
More filters
Journal ArticleDOI

Malignant Cells Can Be Sensitized to Undergo Growth Inhibition and Apoptosis by Arsenic Trioxide Through Modulation of the Glutathione Redox System

TL;DR: Ascorbic acid enhanced the antilymphoma effect of As2O3 in vivo without additional toxicity, and may provide a novel therapy for lymphoma.
Journal ArticleDOI

Arsenic Trioxide Selectively Induces Acute Promyelocytic Leukemia Cell Apoptosis Via a Hydrogen Peroxide-Dependent Pathway

TL;DR: It is shown that the ability of As2O3 to induce apoptosis in leukemic cells is dependent on the activity of the enzymes that regulate cellular H2O2 content, and NB4 cells have relatively low levels of glutathione peroxidase (GPx) and catalase and have a constitutively higher H 2O2content than U937 monocytic leukemia cells.
Journal ArticleDOI

Apoptosis and Growth Inhibition in Malignant Lymphocytes After Treatment With Arsenic Trioxide at Clinically Achievable Concentrations

TL;DR: Substantial growth inhibition and apoptosis without evidence of differentiation were induced in most malignant lymphocytic cells treated with 1-2 μM As 2 O 3, which may prove useful in the treatment ofmalignant lymphoproliferative disorders.
Journal ArticleDOI

Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo.

TL;DR: Combined As(2)O(3) and tRA treatment may be more effective than single agents in tRA-resistant patients, and toxicity and potential drug antagonism may be diminished when given at the same time with therapeutic levels of tRA.
Journal ArticleDOI

Antineoplastic Agents III: Steroidal Glycosides from Solanum nigrum

TL;DR: The cytotoxic assay indicated that 2 is the main antineoplastic agent in S. nigrum, and the structures of 1-3 were elucidated on the basis of chemical evidence and spectral analysis, especially by 2D-NMR analysis.